{"ticker": {"uuid": "d329d34e-ca40-42d6-8284-9b0651071535", "symbol": "SYRE", "name": "Spyre Therapeutics Inc.", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Why Spyre Therapeutics (SYRE) Stock Is Up Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxNLWMtT3JNYW5fbGJLQnlHQnNybkxDc2ZkTlJvR1lTcld5NDZVc2l6d0xodkJwSXQyaFRvUHRmVGU0Zm1UeFZQU1B5ZTBkbnpWSExFekZ2SGFvVHRVYlBYR2M3YjRBVjFkMHM0OFFYckJCblRla3BveTNRR2JNQUpPdTRtb0FxekJ2SzctOQ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-07-14T18:36:00+00:00", "published_display": "14 Jul 2026 18:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Mizuho Raises Price Target on Spyre Therapeutics to $120 From $84, Keeps Outperform Rating", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/mizuho-raises-price-target-spyre-105853884.html", "source_name": "MT Newswires", "published_at": "2026-07-13T10:58:53+00:00", "published_display": "13 Jul 2026 10:58", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 96, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SYRE News | SPYRE THERAPEUTICS INC (NASDAQ:SYRE)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiW0FVX3lxTE81emtaTld6NU5jNjE4cnhlZkJEUTVINE9iRHdIX0hONGZQQVVMQzVaLUJkampob1BaNHFTYjZxREFVN2htTndZM3NBUWptdUpPYUNjVFppcmJnRjQ?oc=5", "source_name": "ChartMill", "published_at": "2026-07-11T00:00:01+00:00", "published_display": "11 Jul 2026 00:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spyre Therapeutics (SYRE) Faces Broad Russell Index Removal Is Benchmark Appeal Quietly Eroding?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-10T02:27:37+00:00", "published_display": "10 Jul 2026 02:27", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spyre Therapeutics Insider Sold Shares Worth $1,315,346, According to a Recent SEC Filing", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/spyre-therapeutics-insider-sold-shares-075301802.html", "source_name": "MT Newswires", "published_at": "2026-07-06T07:53:01+00:00", "published_display": "06 Jul 2026 07:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spyre Therapeutics Announces Grants of Inducement Awards", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/spyre-therapeutics-announces-grants-inducement-200500269.html", "source_name": "GlobeNewswire", "published_at": "2026-07-02T20:05:00+00:00", "published_display": "02 Jul 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spyre Therapeutics (SYRE) CFO exercises options, sells 7,500 shares under 10b5-1 plan", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxNeVVqakMzSlhqUDZHLXV2M3hHQjk4UHdTeUVqSzRLNWhFdENRRE5LRmFkNUxUWF9QRS1xNXBxU3pWS21Ja2dzRTRPN2VWVWhDOHFLUmZpTnFmOTlaTDN5YVZnZGpENTB6cFFxa3FuWlJIWHl3Q3dxQzhRRzRSSEdWa0twZWxwWTliVWJCbGlIZ1hVZ3lvVXllSEYtVmJTNlNDYWFVUU1MR0NzRUJsOWROdVNUM2hWYXM?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spyre gives six new hires equity awards worth 58,843 options", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxOSHFCM2Rtd1ZldDRkYm5Pckxhb1VtbWY1QXk3Y0l3WjFVd2xQQkp1dVRQRnBpZ3ZpMTJGd3M0UUlFUEI5ZkxkenAyWXU2T3gzN0RQQWdPeG5kSzFXN1VaZ2libXBDbzJOTXVET1ZPRHFCR2VFT1l6WnJJengzSGFtNEI3OFp2ZXdYQ2tWZXNBOTd6Z25tQUpoVmRJN05vWVh6akpnWHpVWQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SYRE (NASDAQ) Form 144: Insider sales and 45,000-share notice", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxPLTN6LXhiOS1oWlBGMkJ1ZF9JeDRjSm1femx4dWFXYnpwNGJ3OFRkTGJLbjNtZ0otQmZLLVFaTVpnekU3WkRNNWF4cUF0SllDNS1fRHZZeGl4bU5KQzg2Y1lQU1I1cnA5UFFBOGY5UFB6R2pSeXgtajR2cld4ZUZ3aUIyRDg3b040RG1CaFBuS2ttZ191UHg1NGY2Yi1SU2xY?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spyre Therapeutics: Deep And Diverse Immunology Pipeline Awaiting Data (NASDAQ:SYRE)", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxOVi1SVWkzbTRkOEl0ckpBWUhyQ3pkQmdUQXkwVnN6RkdUbHlmUUl2Q0UtWlNHN1ZaRnp4WG9ZbE5Eek5SUlJRS3ZxeHl0SEZFUDNVcGRrakFRQkJaSEJaUHFoNnJqd1FLRWhaOUNQbFNEV3lJRnBiQm1pNVhYcjNvZkVXNUFDd0NmWkIwbmlJSUVsTUZxOU4xUDBwLWVFNXlQZFc2Q2UwaFVwNm5MR0pJ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spyre Therapeutics Insider Sold Shares Worth $1,307,000, According to a Recent SEC Filing", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/spyre-therapeutics-insider-sold-shares-071637286.html", "source_name": "MT Newswires", "published_at": "2026-06-29T07:16:37+00:00", "published_display": "29 Jun 2026 07:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spyre Therapeutics Stock Outlook Hinges on 2026 Study Catalysts", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxNcDFCOHlBZUpBbzZYc212dkpJck4wMGFwRC1ucDZXNzNHV0thMlZROUtWUXZNZG1jTW1jVDRIVVVvX0RDSW5qc2NCdzJZa2piUTd6bzFnelRzWHNPdW1udi14aWhKR1QwbzVlT2E1MWJoZDVYcTlYQTFQc0Q4d2Yydm1Hb0FHaDcxcC13TGFWYm14cWZqbExBNVJhQWd1YnZnU3c?oc=5", "source_name": "Market source", "published_at": "2026-06-29T07:00:00+00:00", "published_display": "29 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spyre Therapeutics (NASDAQ: SYRE) launches $500M at\u2011the\u2011market program", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxQMUZmWlVfT2lLeklxRExsbzlhR1BGMlB1aUtWVjN2SXVsNmloWUZzSGU4cDRFSHM1aU1KeF9LMjNITWVDWDVNWHdLcHRzZHp1Mi1TVlE0ZW00bGRWMUtNWnNhdElKTHpTZ0I5b2NQU3QwUFlaVjVUMUx1b1pHaUpqVFpkd2xteDYtOGdVaVVkeDFFaW9kcHdOd3RuQ0hDdWpXdnFSXw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-26T07:00:00+00:00", "published_display": "26 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spyre Therapeutics CFO Burrows sells $1.3m in SYRE stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPQ2tmLWNVSDB4S0dZY3JuTjdXcUs5NjBUZGNFSzlKTVYwSUFMOGxOU2tzMUZnbV9hc2hWbmZ6amoxWjYxelJ3Vk0zVEY1RVVtNXNiOExuZllNWE9aWjgweTRSenVhdU1DN0VLRnJUNV9SUjJlZ1BiRmp5MU92RV9YV09NTlEydzE1TWFLRG5aMV82MXdqRnZsSmNndGs1dTREQnQwNXE4bVg4QS1sVTZkb0ZfYlVkWTRTVXA4?oc=5", "source_name": "Investing.com", "published_at": "2026-06-26T07:00:00+00:00", "published_display": "26 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SYRE (NASDAQ): Affiliate files Form 144 to sell 15,000 shares on 06/25/2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxQdW9oRjg4QmZiVDgxZ2pIRGpNMlI2akJNSFNQRThGUS1kUFlkY25wcndMSFNyX29vR09lc2UzbExXU0hweHFsemtwUzNNMTd1NmM5NEVTZXc1dW9ERU1yVW9TNDF3UjEweF8yRDctS2xmOEY3RjVTSWVzMFM4a0NCYjNPZUdCWTFxWmh3UlVMNzRMc1l0U3k3aXRCMXhtQmw0?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spyre Therapeutics Shares Fall After Director Sells $2 Million in Stock", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/spyre-therapeutics-shares-fall-director-184011808.html", "source_name": "MT Newswires", "published_at": "2026-06-24T18:40:11+00:00", "published_display": "24 Jun 2026 18:40", "sentiment": "negative", "sentiment_pct": 30, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spyre Therapeutics Insider Sold Shares Worth $2,000,000, According to a Recent SEC Filing", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/spyre-therapeutics-insider-sold-shares-073931209.html", "source_name": "MT Newswires", "published_at": "2026-06-24T07:39:31+00:00", "published_display": "24 Jun 2026 07:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spyre Therapeutics Shares Slide Following Large Insider Stock Sales (SYRE)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQX0h2VXNSX3NCQXBvaWNub2tqbHRGMFJaT2wyVXB0QnlpWmJZa3ZoNDlob2Q3cXVPQ3ZVa3JFUmlHd0FWV0pEOFk5TU1jaUoxYmFWak83RGhTV1paamhTQVlXRENXTThCcUtSbDdVMV9walVCcnJPWEF2dV9BeTg4NlIzQjJCc182VFhEMVdjRFlVeG1mTUtIYjFmdk44QVVqU25yRjlWSU5yUQ?oc=5", "source_name": "Market source", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spyre stock falls after $2M insider sale (SYRE:NASDAQ)", "summary": "", "url": "https://news.google.com/rss/articles/CBMie0FVX3lxTE9fbld6bDVWNWpoUEFRMV9wVVA1RGFyQmIzcWRXMlJLSFByaG5USU9SSV9NNERMcmV2a1RYQUMyU3VOU0Z4OTVEVXRGRWxHOXNDYjZjUTc4YnpyT1ROeHlRU0tMNzZ2UU5wdVhJXzkzQXJsSU9FbVJ6OFBVRQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Deutsche Bank Adjusts Spyre Therapeutics Price Target to $135 From $115, Maintains Buy Rating", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/deutsche-bank-adjusts-spyre-therapeutics-112748231.html", "source_name": "MT Newswires", "published_at": "2026-06-23T11:27:48+00:00", "published_display": "23 Jun 2026 11:27", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spyre (SYRE) fund converts Series B preferred, then exits common stake", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxNcnRRTXlpSkVIa3BiREJMTEQyb1RoSnMzME5PMW9ISEdqXzFaOE1aX0dJNDlzTmdsWEprRFVDdk1kQkdhbjB6OWFhN0xHTW81MXFsWUdSNl94TWI5enZ6a05sNXVTODBIVlFMLUgweFJERXBfRTFXeXdrUHVCNDlYNVd0cXdwV0dla1o3T0JCVmtKcDgwMkhyeHJKN3VSdWo1Q2FDZ3RBSVBZVFhkeE5YUzJfRGFDbW8?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director at Spyre Therapeutics (SYRE) sells 20,000 shares under 10b5-1 plan", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxPdDVBa2ZQZURUOEdHUmhMVnFpMjQtczhvQmViQkRWWEE5XzdpM1d3LTVzUXo5RFZkREZ2c0V2REhZTElHTjQydlIzdTBDWUwtV2JRV2NhNTNQOXd2Q3VBZENWRlBHNGZiM3Q5Smd2TWdGX3VMc2xWM3ljQ1VsMnJELVl6clZuTGxwV3BoU0xLWU5JSmlBNWFYLUVLLTIwUUZMdF8yM0hMQ1daUjJURWpsQXRzRHB6Vm8?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spyre Therapeutics (SYRE) CMO sells 8,333 shares, retains 313,334 options", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxPYkNHSVNENk1xX2duRzJOWGItSXZwa2xyS3RMRG1SNkpaSFhpZTZCaUJxWHZDQkNyRFRhNVB4X1JXXzVuVlBLODFmRFkzSHlFTThIb2lKdkpKZGpObmVkc2F1Ty1ZT21xaG9CSDV0UEgxZldpNmE1aFNSWFU4TDFhTlYyb1NYdlZKMDlYVlR6MV9fUlFiREJ5QjdVU1dTM2pISjlaY2ExRmRMVEtlRGVzckx5V2J0NDg?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spyre finishes arthritis trial enrollment, targets 2026 results in three diseases", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxNZ3ctT2J3R0xhc1FMZEtzVW5LVGRpeHVIdlNUZXZhS2hVcEx1b2pQa2tsaDg5RkozcTdJSXhJTlFUbDRYNUNUSDlOTDdrU1FQYWtiZUVzTTZlLWZtZlVPVGVDcEUwR05zVlVaUE1sVVJnQTBaWEVDdlNWYmFhMlJ6SEV4RDBnMk5EeF9PTnVkeVBTNDU3eFBMdEYxNWpOVENqZWJXVTBXOFY0N2FnOWpwLUpvQVBlbnlJbEE?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxOWWM3V1pmZzdlY1llRTljQmNLQ2UwdDdQaFVEcng2WVdrNE9qNzRrNVpBVlJNMGltQUhBUG1qellCVHNiM09fUkFHRW1kMEpvazJoLU11N3c4YnlWUXpmVl82aWNKeTA4U1RwSHNNSVd4d0lwWHRJclQ2TGNHWUpBQTgzbTBMVk05VGxYN0RwcmpTYklOQUFSWDhsSHZlQVpndmlPRGNvTmRmeHNILWg4ZE5jMjRoN01XNENiaVU2UDUyOWJfYUZCTm5URmtwTHJsTjJYNHo3RkxsQjBSMnBmdVZVWkFwN2PSAewBQVVfeXFMT3htM016bEt0TTdyOXE2amppMGpubTNfOFU4cGpxd2dFZkJDTjR3c0ZqOHpHYWZoamNLdmkxVmNYNklxTEM4NTU0bDZwUTZ1SW5Jc1c4NmRJN3lKQUVqUUNYYWptd2ZYNE9TeEhMRzFvbEt0bjk1TVhyVG44UnJnNDllTlFsalJVUTZwcEEzWXljbzdaQXdWWDlHQW56bGxqeG90UlFmaFFLekJlUlNIOVE4SGNHcE9pOW1KSllleVdwNERiaVl2NmxtNTNyaUtnSFY1VHUzcDJsWE9xb3R1ajZ2RGhkXzJzTldMOVA?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Is Spyre Therapeutics (SYRE) One of the Small-Cap Stocks That Are On Fire Right Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNYWR1TU5OZzdfWF9tQ3NEb2lYT0prY3dxVW1MbVFYempvTWlpbDVkVUo3Uk0weFZVaXduMXJETjE5X0ZCOEFMeG4ybzZZVE00RzduMklJM2NoYnpSWk1NcFZhQjJXRjl4WEpyRGNmYmxtV3MyX2U4NFpIbjB5eG9SMTM1TTI5VzZCZkY1T2l4dUI0QVYxeTBwM3RtaU90cDQ?oc=5", "source_name": "Market source", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spyre Therapeutics (SYRE): Favorite Stock of Elite Money Managers", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOaUZyNWxkV2xjYUhUbC1RelJOOHFka0ZOVEIzSThuRUtZVGxGX2xyQ1hyckl3UW94VzRheVI3TWF3Tl9MVkNxV3VHdXFtb1A0QjRhWEktd1dmRDVpQ05ULThwSDA0aFAxdHJmOXJUNmZIWUpOTEpKSW1WU2ZOU3FxN2Y5RFdvcGQ0NEpZdnFMMlh3RC10Q25ndUlKMlVaQXlfdlhUc1FR?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Here\u2019s What Raymond James Says About Spyre Therapeutics Inc (SYRE)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNYU5uRGg2RHNjak1WeXoybUJtcUMtd01TTVlGeHRHcDEwY3hZRjlKT1cwTHlhZC1XX2psZ212RUVsaWZHckRMSm1WempXNTlsNGVud044WGxOXzBvZ1UtMWxHRGJVWXNjSGNmZmxLTUlnM0xNNV9XWVppbzNQZTZuVlN0d2NyUEtVaDFKQ3FfbjdPRGozSHVQbnQxOUJwVHNjaGtqUjBTeGRMZw?oc=5", "source_name": "Market source", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Perceptive (NASDAQ: SYRE) reports 4.32M shares, 5.0% stake", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxPMlJaeFFrb25nT0c4d3VLT0gxY0lqZFBJVWFiS3NsU1JTLXZHbXJEb1AwNXVYNUZOTUdzY3BuYTJGUk14cU1acXRkSXU0R0lJcjYyaGZaWW5uMnZ2bmxfX1NVTUQ5MC1KeEVYSWRUWDdsdjFuZDgtT1hrYktyY0RlU1dqRlUwaVVUc2lVNEpxOVhlSFM2RWk4Nl82VlpFX2ZiSGdLbWV0bGhiZXpveEJsQ21aNldIb3N4YmhxYjRCaWxqLU9pWjVVZw?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Spyre (SYRE) Climbs 42% as Treatment Candidate Poses \u2018Best-in-Class\u2019 Potential", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNMmk5d2YzLXZpS1NfVmpFU1lYSlFKQlYxUXR3dFNuNXNXdTd5WGZYZ1BpdkhPWWZuam12YWtRcjZDWkVTSUNxWUNHRDNiTlBHUzFFbVhHQ3JxVXNWUU5YZTZzY05jekhMYVpzTkxoUkhhODN6U3JKRUIxbUdkLWFqM0tBWi1YV3A5UHJ4dGNwZTNqWEpCV0d6MWxJNA?oc=5", "source_name": "Market source", "published_at": "2026-04-19T07:00:00+00:00", "published_display": "19 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spyre pulls in $463.5M after underwriters take all extra shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxQSU1wVks5XzloZTZNWWJvVmR3bHdJQ0JnV1pIa3R1cXRCb1BEWXpVN1dKa0dWc2tDb2xqQ1V0NFBKUml3WGo5QmQwWkdhWVk3TUtDWVNvbGdJWE9SMHBHQ2xmbkJqbF9Tb3ZFbW81dDdSbHdGMjM3Mk1RZFo5VWFrR2hsSUs2eUxuMERhOG9WcmU0Qjh2cDhBTUoyaWVZRnZVSlBHemZ2NzZfR1I3SWFkSHdxR2MzV1lvQk8xNWRQWk4?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-16T07:00:00+00:00", "published_display": "16 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spyre Therapeutics Announces $403 Million Public Offering of Common Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxONVVPc1RxQXM3QXU0T0IwcGN5cEotX0d0YnpzOVE2cl9MSXBoUWNvNnBxaWE5V1VDRU4xYU5ya0tLakpjVmV6RngyVHJLUmZZeTl5aVRBNy1jbmlsU2s2VDRzRFN6Vm5rRHpUS2VFWGk5U0gwSy1MdTFfQVJjMHppSGNwYVhaV1pFQVRUU1VnQ1AzOVdUaDBQNFVQT3ZkVjVma09nb1hzR3NzNG9n?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-04-15T07:00:00+00:00", "published_display": "15 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spyre moves to raise $300M, with room to expand the sale to $345M", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPUEJ3UkJLY1RPWXNhM0pmcmZVblZhQTZKUVFCTXBLbjZQZFo2dE1KMGJBczNvMkMzVEEzWkhMT1BqSTRiR0ZscWtjU0Zzd2V4WmhtckVlYTVJTl9pS2l6UGVFTHRiSjdUVkVqZC1qSVYtckdoUVFaak1INE1CUEdVSFNvcHZsRmN5ekNOVDQtdEdla3NIbk5vUW9WcFdPNnpqOURuNk43WDdQSnhNM3doZzF0MkhSMmFCZklhOExMUQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-13T07:00:00+00:00", "published_display": "13 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Spyre Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4wFBVV95cUxQNWNiejNiaDZjSzdrQ0J5eWNfbU9PRGM4X3Y2dE9ZVlM2cmprcWY0bl85azJsR3lvM2NsMGw4LV85MWhwZ2hCVW1WMlNVVTB2UHdkOU9GWDlqWU91WHc2UGR0eVMxSzcza3lrSDdtV0k1WEE5dE1kb1VveFBqY3c2VVMwaGJQUFRIWnlmdDZ2UDFkcWZXNE9iVXRQLW1TQkpGSHZBbUItN3paUmZENnh5VWdPQk1HRUhIbkV6Y2FSMmIzWE84YjRESWJHSVdTZ1c0SDYtYVp6VmllSFF4Rk11MFNTaw?oc=5", "source_name": "PR Newswire", "published_at": "2025-05-08T07:00:00+00:00", "published_display": "08 May 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spyre Therapeutics Announces $180 Million Private Placement", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxQbkJPaDQ4dzdGR202dnRuOVNnLXQxb1lic3VyM2dqZ25ieGVLUncySUNyUnZZemMwMDVaS1BNUDFORXhCc2FxSzJoNFAzajF5SnR6QUg2eVlaS2ZDZm5yM0Z3OWVSMm5LYkpaS20weWpDWEptRmZNLUxqbmpIR1JDcnhUeTJjXzZYMkRiVlE2eXdxdnNUdmlOTE41X2h1NXdXck5waDZBdzlMT2wxUHdvTHMzWkE?oc=5", "source_name": "PR Newswire", "published_at": "2024-03-18T07:00:00+00:00", "published_display": "18 Mar 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Why Spyre Therapeutics (SYRE) Stock Is Up Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxNLWMtT3JNYW5fbGJLQnlHQnNybkxDc2ZkTlJvR1lTcld5NDZVc2l6d0xodkJwSXQyaFRvUHRmVGU0Zm1UeFZQU1B5ZTBkbnpWSExFekZ2SGFvVHRVYlBYR2M3YjRBVjFkMHM0OFFYckJCblRla3BveTNRR2JNQUpPdTRtb0FxekJ2SzctOQ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-07-14T18:36:00+00:00", "published_display": "14 Jul 2026 18:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mizuho Raises Price Target on Spyre Therapeutics to $120 From $84, Keeps Outperform Rating", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/mizuho-raises-price-target-spyre-105853884.html", "source_name": "MT Newswires", "published_at": "2026-07-13T10:58:53+00:00", "published_display": "13 Jul 2026 10:58", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 96, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SYRE News | SPYRE THERAPEUTICS INC (NASDAQ:SYRE)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiW0FVX3lxTE81emtaTld6NU5jNjE4cnhlZkJEUTVINE9iRHdIX0hONGZQQVVMQzVaLUJkampob1BaNHFTYjZxREFVN2htTndZM3NBUWptdUpPYUNjVFppcmJnRjQ?oc=5", "source_name": "ChartMill", "published_at": "2026-07-11T00:00:01+00:00", "published_display": "11 Jul 2026 00:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spyre Therapeutics (SYRE) Faces Broad Russell Index Removal Is Benchmark Appeal Quietly Eroding?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxOSmVzSWZXYzIxU2hXZ29NLVR6OTI5WVF6czZJajhCTHA4VmluU3ZoQUEwdzlsNnVLMHgxS2ROeUdnVzNzd09jbFlBQV9ZdUR6MTZyWHBrRFRqRmZtSEh6UDlKMzEtUGpIR3l1NEdEcmh6VEJBQVZneklUWGhtcXFiaTBoV2lhZGhoREVFTHRpTkMwNW94SVl0eGUyc2JXN3NjU0lrZk9JTmh0QmpNZjRzblRKTnFWRHhPMmN2YkEwenF5UXRSVDdKekdFUFJZcWxrLXVYZlg3WjYxVERhemlfX1pJaTBnbEHSAewBQVVfeXFMUHhHM0IzUS16RklkX29tcXJKcEx6eDkzb094aGJKMmlQSC1GZkZPOVRCSFdVNHRQczZaZkhtTkt5Q3BzMHk2OXpUc3FLMHJybjdVM3pKNWZIQnhoY3hRemhUeUR4M000c0FXUkpuYzJURExXSGl2NEU0WmRCUXNiN1BxYlNEQldQV19BUWxjUkxxcWh4UW5JeTBiUFFVX2FRc1E4OE9Lb3ctZmMza1RJUkpTSGFKalAtZFlyZEI2OUFEVjZtRjFtWFJBaGJuVE40LVhKd0R6V0FIMVVkdURVdTlMdnFqYy1IX0JDMVM?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-10T02:27:37+00:00", "published_display": "10 Jul 2026 02:27", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spyre Therapeutics Insider Sold Shares Worth $1,315,346, According to a Recent SEC Filing", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/spyre-therapeutics-insider-sold-shares-075301802.html", "source_name": "MT Newswires", "published_at": "2026-07-06T07:53:01+00:00", "published_display": "06 Jul 2026 07:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spyre Therapeutics Announces Grants of Inducement Awards", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/spyre-therapeutics-announces-grants-inducement-200500269.html", "source_name": "GlobeNewswire", "published_at": "2026-07-02T20:05:00+00:00", "published_display": "02 Jul 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spyre Therapeutics (SYRE) CFO exercises options, sells 7,500 shares under 10b5-1 plan", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxNeVVqakMzSlhqUDZHLXV2M3hHQjk4UHdTeUVqSzRLNWhFdENRRE5LRmFkNUxUWF9QRS1xNXBxU3pWS21Ja2dzRTRPN2VWVWhDOHFLUmZpTnFmOTlaTDN5YVZnZGpENTB6cFFxa3FuWlJIWHl3Q3dxQzhRRzRSSEdWa0twZWxwWTliVWJCbGlIZ1hVZ3lvVXllSEYtVmJTNlNDYWFVUU1MR0NzRUJsOWROdVNUM2hWYXM?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spyre gives six new hires equity awards worth 58,843 options", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxOSHFCM2Rtd1ZldDRkYm5Pckxhb1VtbWY1QXk3Y0l3WjFVd2xQQkp1dVRQRnBpZ3ZpMTJGd3M0UUlFUEI5ZkxkenAyWXU2T3gzN0RQQWdPeG5kSzFXN1VaZ2libXBDbzJOTXVET1ZPRHFCR2VFT1l6WnJJengzSGFtNEI3OFp2ZXdYQ2tWZXNBOTd6Z25tQUpoVmRJN05vWVh6akpnWHpVWQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SYRE (NASDAQ) Form 144: Insider sales and 45,000-share notice", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxPLTN6LXhiOS1oWlBGMkJ1ZF9JeDRjSm1femx4dWFXYnpwNGJ3OFRkTGJLbjNtZ0otQmZLLVFaTVpnekU3WkRNNWF4cUF0SllDNS1fRHZZeGl4bU5KQzg2Y1lQU1I1cnA5UFFBOGY5UFB6R2pSeXgtajR2cld4ZUZ3aUIyRDg3b040RG1CaFBuS2ttZ191UHg1NGY2Yi1SU2xY?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spyre Therapeutics: Deep And Diverse Immunology Pipeline Awaiting Data (NASDAQ:SYRE)", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxOVi1SVWkzbTRkOEl0ckpBWUhyQ3pkQmdUQXkwVnN6RkdUbHlmUUl2Q0UtWlNHN1ZaRnp4WG9ZbE5Eek5SUlJRS3ZxeHl0SEZFUDNVcGRrakFRQkJaSEJaUHFoNnJqd1FLRWhaOUNQbFNEV3lJRnBiQm1pNVhYcjNvZkVXNUFDd0NmWkIwbmlJSUVsTUZxOU4xUDBwLWVFNXlQZFc2Q2UwaFVwNm5MR0pJ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spyre Therapeutics Insider Sold Shares Worth $1,307,000, According to a Recent SEC Filing", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/spyre-therapeutics-insider-sold-shares-071637286.html", "source_name": "MT Newswires", "published_at": "2026-06-29T07:16:37+00:00", "published_display": "29 Jun 2026 07:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spyre Therapeutics Stock Outlook Hinges on 2026 Study Catalysts", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxNcDFCOHlBZUpBbzZYc212dkpJck4wMGFwRC1ucDZXNzNHV0thMlZROUtWUXZNZG1jTW1jVDRIVVVvX0RDSW5qc2NCdzJZa2piUTd6bzFnelRzWHNPdW1udi14aWhKR1QwbzVlT2E1MWJoZDVYcTlYQTFQc0Q4d2Yydm1Hb0FHaDcxcC13TGFWYm14cWZqbExBNVJhQWd1YnZnU3c?oc=5", "source_name": "Market source", "published_at": "2026-06-29T07:00:00+00:00", "published_display": "29 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spyre Therapeutics (NASDAQ: SYRE) launches $500M at\u2011the\u2011market program", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxQMUZmWlVfT2lLeklxRExsbzlhR1BGMlB1aUtWVjN2SXVsNmloWUZzSGU4cDRFSHM1aU1KeF9LMjNITWVDWDVNWHdLcHRzZHp1Mi1TVlE0ZW00bGRWMUtNWnNhdElKTHpTZ0I5b2NQU3QwUFlaVjVUMUx1b1pHaUpqVFpkd2xteDYtOGdVaVVkeDFFaW9kcHdOd3RuQ0hDdWpXdnFSXw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-26T07:00:00+00:00", "published_display": "26 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spyre Therapeutics CFO Burrows sells $1.3m in SYRE stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPQ2tmLWNVSDB4S0dZY3JuTjdXcUs5NjBUZGNFSzlKTVYwSUFMOGxOU2tzMUZnbV9hc2hWbmZ6amoxWjYxelJ3Vk0zVEY1RVVtNXNiOExuZllNWE9aWjgweTRSenVhdU1DN0VLRnJUNV9SUjJlZ1BiRmp5MU92RV9YV09NTlEydzE1TWFLRG5aMV82MXdqRnZsSmNndGs1dTREQnQwNXE4bVg4QS1sVTZkb0ZfYlVkWTRTVXA4?oc=5", "source_name": "Investing.com", "published_at": "2026-06-26T07:00:00+00:00", "published_display": "26 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SYRE (NASDAQ): Affiliate files Form 144 to sell 15,000 shares on 06/25/2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxQdW9oRjg4QmZiVDgxZ2pIRGpNMlI2akJNSFNQRThGUS1kUFlkY25wcndMSFNyX29vR09lc2UzbExXU0hweHFsemtwUzNNMTd1NmM5NEVTZXc1dW9ERU1yVW9TNDF3UjEweF8yRDctS2xmOEY3RjVTSWVzMFM4a0NCYjNPZUdCWTFxWmh3UlVMNzRMc1l0U3k3aXRCMXhtQmw0?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spyre Therapeutics Shares Fall After Director Sells $2 Million in Stock", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/spyre-therapeutics-shares-fall-director-184011808.html", "source_name": "MT Newswires", "published_at": "2026-06-24T18:40:11+00:00", "published_display": "24 Jun 2026 18:40", "sentiment": "negative", "sentiment_pct": 30, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spyre Therapeutics Insider Sold Shares Worth $2,000,000, According to a Recent SEC Filing", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/spyre-therapeutics-insider-sold-shares-073931209.html", "source_name": "MT Newswires", "published_at": "2026-06-24T07:39:31+00:00", "published_display": "24 Jun 2026 07:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spyre Therapeutics Shares Slide Following Large Insider Stock Sales (SYRE)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQX0h2VXNSX3NCQXBvaWNub2tqbHRGMFJaT2wyVXB0QnlpWmJZa3ZoNDlob2Q3cXVPQ3ZVa3JFUmlHd0FWV0pEOFk5TU1jaUoxYmFWak83RGhTV1paamhTQVlXRENXTThCcUtSbDdVMV9walVCcnJPWEF2dV9BeTg4NlIzQjJCc182VFhEMVdjRFlVeG1mTUtIYjFmdk44QVVqU25yRjlWSU5yUQ?oc=5", "source_name": "Market source", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spyre stock falls after $2M insider sale (SYRE:NASDAQ)", "summary": "", "url": "https://news.google.com/rss/articles/CBMie0FVX3lxTE9fbld6bDVWNWpoUEFRMV9wVVA1RGFyQmIzcWRXMlJLSFByaG5USU9SSV9NNERMcmV2a1RYQUMyU3VOU0Z4OTVEVXRGRWxHOXNDYjZjUTc4YnpyT1ROeHlRU0tMNzZ2UU5wdVhJXzkzQXJsSU9FbVJ6OFBVRQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Deutsche Bank Adjusts Spyre Therapeutics Price Target to $135 From $115, Maintains Buy Rating", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/deutsche-bank-adjusts-spyre-therapeutics-112748231.html", "source_name": "MT Newswires", "published_at": "2026-06-23T11:27:48+00:00", "published_display": "23 Jun 2026 11:27", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spyre (SYRE) fund converts Series B preferred, then exits common stake", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxNcnRRTXlpSkVIa3BiREJMTEQyb1RoSnMzME5PMW9ISEdqXzFaOE1aX0dJNDlzTmdsWEprRFVDdk1kQkdhbjB6OWFhN0xHTW81MXFsWUdSNl94TWI5enZ6a05sNXVTODBIVlFMLUgweFJERXBfRTFXeXdrUHVCNDlYNVd0cXdwV0dla1o3T0JCVmtKcDgwMkhyeHJKN3VSdWo1Q2FDZ3RBSVBZVFhkeE5YUzJfRGFDbW8?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director at Spyre Therapeutics (SYRE) sells 20,000 shares under 10b5-1 plan", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxPdDVBa2ZQZURUOEdHUmhMVnFpMjQtczhvQmViQkRWWEE5XzdpM1d3LTVzUXo5RFZkREZ2c0V2REhZTElHTjQydlIzdTBDWUwtV2JRV2NhNTNQOXd2Q3VBZENWRlBHNGZiM3Q5Smd2TWdGX3VMc2xWM3ljQ1VsMnJELVl6clZuTGxwV3BoU0xLWU5JSmlBNWFYLUVLLTIwUUZMdF8yM0hMQ1daUjJURWpsQXRzRHB6Vm8?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spyre Therapeutics (SYRE) CMO sells 8,333 shares, retains 313,334 options", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxPYkNHSVNENk1xX2duRzJOWGItSXZwa2xyS3RMRG1SNkpaSFhpZTZCaUJxWHZDQkNyRFRhNVB4X1JXXzVuVlBLODFmRFkzSHlFTThIb2lKdkpKZGpObmVkc2F1Ty1ZT21xaG9CSDV0UEgxZldpNmE1aFNSWFU4TDFhTlYyb1NYdlZKMDlYVlR6MV9fUlFiREJ5QjdVU1dTM2pISjlaY2ExRmRMVEtlRGVzckx5V2J0NDg?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spyre finishes arthritis trial enrollment, targets 2026 results in three diseases", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxNZ3ctT2J3R0xhc1FMZEtzVW5LVGRpeHVIdlNUZXZhS2hVcEx1b2pQa2tsaDg5RkozcTdJSXhJTlFUbDRYNUNUSDlOTDdrU1FQYWtiZUVzTTZlLWZtZlVPVGVDcEUwR05zVlVaUE1sVVJnQTBaWEVDdlNWYmFhMlJ6SEV4RDBnMk5EeF9PTnVkeVBTNDU3eFBMdEYxNWpOVENqZWJXVTBXOFY0N2FnOWpwLUpvQVBlbnlJbEE?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Spyre Therapeutics (SYRE) One of the Small-Cap Stocks That Are On Fire Right Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNYWR1TU5OZzdfWF9tQ3NEb2lYT0prY3dxVW1MbVFYempvTWlpbDVkVUo3Uk0weFZVaXduMXJETjE5X0ZCOEFMeG4ybzZZVE00RzduMklJM2NoYnpSWk1NcFZhQjJXRjl4WEpyRGNmYmxtV3MyX2U4NFpIbjB5eG9SMTM1TTI5VzZCZkY1T2l4dUI0QVYxeTBwM3RtaU90cDQ?oc=5", "source_name": "Market source", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spyre Therapeutics (SYRE): Favorite Stock of Elite Money Managers", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOaUZyNWxkV2xjYUhUbC1RelJOOHFka0ZOVEIzSThuRUtZVGxGX2xyQ1hyckl3UW94VzRheVI3TWF3Tl9MVkNxV3VHdXFtb1A0QjRhWEktd1dmRDVpQ05ULThwSDA0aFAxdHJmOXJUNmZIWUpOTEpKSW1WU2ZOU3FxN2Y5RFdvcGQ0NEpZdnFMMlh3RC10Q25ndUlKMlVaQXlfdlhUc1FR?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here\u2019s What Raymond James Says About Spyre Therapeutics Inc (SYRE)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNYU5uRGg2RHNjak1WeXoybUJtcUMtd01TTVlGeHRHcDEwY3hZRjlKT1cwTHlhZC1XX2psZ212RUVsaWZHckRMSm1WempXNTlsNGVud044WGxOXzBvZ1UtMWxHRGJVWXNjSGNmZmxLTUlnM0xNNV9XWVppbzNQZTZuVlN0d2NyUEtVaDFKQ3FfbjdPRGozSHVQbnQxOUJwVHNjaGtqUjBTeGRMZw?oc=5", "source_name": "Market source", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Perceptive (NASDAQ: SYRE) reports 4.32M shares, 5.0% stake", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxPMlJaeFFrb25nT0c4d3VLT0gxY0lqZFBJVWFiS3NsU1JTLXZHbXJEb1AwNXVYNUZOTUdzY3BuYTJGUk14cU1acXRkSXU0R0lJcjYyaGZaWW5uMnZ2bmxfX1NVTUQ5MC1KeEVYSWRUWDdsdjFuZDgtT1hrYktyY0RlU1dqRlUwaVVUc2lVNEpxOVhlSFM2RWk4Nl82VlpFX2ZiSGdLbWV0bGhiZXpveEJsQ21aNldIb3N4YmhxYjRCaWxqLU9pWjVVZw?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spyre (SYRE) Climbs 42% as Treatment Candidate Poses \u2018Best-in-Class\u2019 Potential", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNMmk5d2YzLXZpS1NfVmpFU1lYSlFKQlYxUXR3dFNuNXNXdTd5WGZYZ1BpdkhPWWZuam12YWtRcjZDWkVTSUNxWUNHRDNiTlBHUzFFbVhHQ3JxVXNWUU5YZTZzY05jekhMYVpzTkxoUkhhODN6U3JKRUIxbUdkLWFqM0tBWi1YV3A5UHJ4dGNwZTNqWEpCV0d6MWxJNA?oc=5", "source_name": "Market source", "published_at": "2026-04-19T07:00:00+00:00", "published_display": "19 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spyre pulls in $463.5M after underwriters take all extra shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxQSU1wVks5XzloZTZNWWJvVmR3bHdJQ0JnV1pIa3R1cXRCb1BEWXpVN1dKa0dWc2tDb2xqQ1V0NFBKUml3WGo5QmQwWkdhWVk3TUtDWVNvbGdJWE9SMHBHQ2xmbkJqbF9Tb3ZFbW81dDdSbHdGMjM3Mk1RZFo5VWFrR2hsSUs2eUxuMERhOG9WcmU0Qjh2cDhBTUoyaWVZRnZVSlBHemZ2NzZfR1I3SWFkSHdxR2MzV1lvQk8xNWRQWk4?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-16T07:00:00+00:00", "published_display": "16 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spyre Therapeutics Announces $403 Million Public Offering of Common Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxONVVPc1RxQXM3QXU0T0IwcGN5cEotX0d0YnpzOVE2cl9MSXBoUWNvNnBxaWE5V1VDRU4xYU5ya0tLakpjVmV6RngyVHJLUmZZeTl5aVRBNy1jbmlsU2s2VDRzRFN6Vm5rRHpUS2VFWGk5U0gwSy1MdTFfQVJjMHppSGNwYVhaV1pFQVRUU1VnQ1AzOVdUaDBQNFVQT3ZkVjVma09nb1hzR3NzNG9n?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-04-15T07:00:00+00:00", "published_display": "15 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spyre moves to raise $300M, with room to expand the sale to $345M", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPUEJ3UkJLY1RPWXNhM0pmcmZVblZhQTZKUVFCTXBLbjZQZFo2dE1KMGJBczNvMkMzVEEzWkhMT1BqSTRiR0ZscWtjU0Zzd2V4WmhtckVlYTVJTl9pS2l6UGVFTHRiSjdUVkVqZC1qSVYtckdoUVFaak1INE1CUEdVSFNvcHZsRmN5ekNOVDQtdEdla3NIbk5vUW9WcFdPNnpqOURuNk43WDdQSnhNM3doZzF0MkhSMmFCZklhOExMUQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-13T07:00:00+00:00", "published_display": "13 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spyre Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4wFBVV95cUxQNWNiejNiaDZjSzdrQ0J5eWNfbU9PRGM4X3Y2dE9ZVlM2cmprcWY0bl85azJsR3lvM2NsMGw4LV85MWhwZ2hCVW1WMlNVVTB2UHdkOU9GWDlqWU91WHc2UGR0eVMxSzcza3lrSDdtV0k1WEE5dE1kb1VveFBqY3c2VVMwaGJQUFRIWnlmdDZ2UDFkcWZXNE9iVXRQLW1TQkpGSHZBbUItN3paUmZENnh5VWdPQk1HRUhIbkV6Y2FSMmIzWE84YjRESWJHSVdTZ1c0SDYtYVp6VmllSFF4Rk11MFNTaw?oc=5", "source_name": "PR Newswire", "published_at": "2025-05-08T07:00:00+00:00", "published_display": "08 May 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spyre Therapeutics Announces $180 Million Private Placement", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxQbkJPaDQ4dzdGR202dnRuOVNnLXQxb1lic3VyM2dqZ25ieGVLUncySUNyUnZZemMwMDVaS1BNUDFORXhCc2FxSzJoNFAzajF5SnR6QUg2eVlaS2ZDZm5yM0Z3OWVSMm5LYkpaS20weWpDWEptRmZNLUxqbmpIR1JDcnhUeTJjXzZYMkRiVlE2eXdxdnNUdmlOTE41X2h1NXdXck5waDZBdzlMT2wxUHdvTHMzWkE?oc=5", "source_name": "PR Newswire", "published_at": "2024-03-18T07:00:00+00:00", "published_display": "18 Mar 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 80, "total_relevant": 42, "sentiment_summary": {"positive": 4, "negative": 4, "neutral": 34, "score": 49, "total": 42, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 84, "events": [{"event": "general", "label": "Market update", "weight": 15.55, "count": 27}, {"event": "earnings", "label": "Earnings", "weight": 4.4, "count": 10}, {"event": "analyst", "label": "Analyst action", "weight": 1.1, "count": 2}, {"event": "deals", "label": "Deals and strategy", "weight": 1.1, "count": 2}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}], "positive_events": 4, "negative_events": 4}, "market_context": {"has_market_context": true, "latest_close": 97.74, "latest_week": "2026-07-10", "one_week_move": 12.8, "four_week_move": 21.0, "twelve_week_move": 33.9, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 1.474699, "market_dynamics_buy_signal": false, "relative_strength": 112.859183, "fair_value_gap": 237.8, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "undecided", "expectation_probability": 53.573, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+12.8% over one week, +21.0% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 61, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 12}, {"label": "Market source", "count": 11}, {"label": "MT Newswires", "count": 6}, {"label": "simplywall.st", "count": 3}, {"label": "Quiver Quantitative", "count": 2}, {"label": "Seeking Alpha", "count": 2}, {"label": "PR Newswire", "count": 2}, {"label": "ChartMill", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 34}, {"label": "Industry context", "count": 8}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 27}, {"label": "Earnings", "count": 10}, {"label": "Analyst action", "count": 2}, {"label": "Deals and strategy", "count": 2}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "49/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "84/100 classification confidence."}, {"label": "Company focus", "value": "34", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "2", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+12.8% over one week, +21.0% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Why Spyre Therapeutics (SYRE) Stock Is Up Today"}], "updated_at": "2026-07-16T12:57:09.012885+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}